Nuclea Biotechnologies, Inc. — Form D/A

Nuclea Biotechnologies, Inc. of PITTSFIELD, MA, a company, filed a Form D amendment with the SEC on 2009-10-22. $3.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
William R HarmanDirectorNEW YORK, NY
Dennis K StoneDirectorHouston, TX
Richard R VietorDirectorSt. Louis, MO
Patrick J MuracaDirectorPittsfield, MA
Patrick J MuracaExecutive OfficerPittsfield, MA
Robert J PierceExecutive OfficerPittsfield, MA
Paula J EvansExecutive OfficerPittsfield, MA
Charles P StetsonDirectorPittsfield, MA
James W LewisDirectorJersey City, NJ
Richard W VietorDirectorPittsfield, MA
PAULA C EVANSExecutive OfficerPITTSFIELD, MA
Richard R. VietorDirectorPittsfield, MA
Patrick J. MuracaDirectorPittsfield, MA
Patrick J. MuracaExecutive OfficerPittsfield, MA
Robert J. PierceExecutive OfficerPittsfield, MA
Paula J. EvansExecutive OfficerPittsfield, MA
Charles P. StetsonDirectorPittsfield, MA
William R. HarmanDirectorPittsfield, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2013-02-20D$1.1M
2012-08-08D$5.0M
2012-05-03D$555K
2012-04-11D$1.9M
2011-08-18D$3.0M
2010-12-17D$4.0M$425K
2010-12-08D
2010-11-01D/A$8.9M
2009-06-24D$3.0M$1.0M

More